I agree that this site is using cookies. You can find further informations here.
X
Schmidt, Jurema
33  results:
Search for persons X
?
1

A New FXR Ligand Chemotype with Agonist/Antagonist Switch:

Helmstädter, Moritz ; Vietor, Jan ; Sommer, Jana...
ACS Medicinal Chemistry Letters.  12 (2021)  2 - p. 267-274 , 2021
Link: https://doi.org/10.1021/..
 
?
2

Differential Therapeutic Effects of FXR Activation, sEH Inh..:

Helmstädter, Moritz ; Schmidt, Jurema ; Kaiser, Astrid...
ACS Pharmacology & Translational Science.  4 (2021)  2 - p. 966-979 , 2021
Link: https://doi.org/10.1021/..
 
?
3

Second-Generation Dual FXR/sEH Modulators with Optimized Ph..:

Helmstädter, Moritz ; Kaiser, Astrid ; Brunst, Steffen...
Journal of Medicinal Chemistry.  64 (2021)  13 - p. 9525-9536 , 2021
Link: https://doi.org/10.1021/..
 
?
4

A triple farnesoid X receptor and peroxisome proliferator-a..:

Heitel, Pascal ; Faudone, Giuseppe ; Helmstädter, Moritz...
Communications Chemistry.  3 (2020)  1 - p. , 2020
Link: https://doi.org/10.1038/..
 
?
5

Dual Farnesoid X Receptor/Soluble Epoxide Hydrolase Modulat..:

Schierle, Simone ; Helmstädter, Moritz ; Schmidt, Jurema...
ChemMedChem.  15 (2019)  1 - p. 50-67 , 2019
Link: https://doi.org/10.1002/..
 
?
6

Tuning Nuclear Receptor Selectivity of Wy14,643 towards Sel..:

Pollinger, Julius ; Gellrich, Leonie ; Schierle, Simone...
Journal of Medicinal Chemistry.  62 (2019)  4 - p. 2112-2126 , 2019
Link: https://doi.org/10.1021/..
 
?
7

A Dual Farnesoid X Receptor Agonist /Soluble Epoxide Hydrol..:

Khan, Abdul Hye ; Stavniichuk, Anna ; Schmidt, Jurema..
The FASEB Journal.  33 (2019)  S1 - p. , 2019
Link: https://doi.org/10.1096/..
 
?
8

A dual farnesoid X receptor/soluble epoxide hydrolase modul..:

Hye Khan, Md. Abdul ; Schmidt, Jurema ; Stavniichuk, Anna..
Biochemical Pharmacology.  166 (2019)  - p. 212-221 , 2019
Link: https://doi.org/10.1016/..
 
?
9

Entwicklung und Charakterisierung neuer Farnesoid X Rezepto..:

Schmidt, Jurema , 2018
Link: https://nbn-resolving.de..
 
?
10

Structural optimization and in vitro profiling of N-phenylb..:

Schmidt, Jurema ; Schierle, Simone ; Gellrich, Leonie..
Bioorganic & Medicinal Chemistry.  26 (2018)  14 - p. 4240-4253 , 2018
Link: https://doi.org/10.1016/..
 
?
11

Allosteric modulation of the farnesoid X receptor by a smal..:

Gabler, Matthias ; Kramer, Jan ; Schmidt, Jurema...
Scientific Reports.  8 (2018)  1 - p. , 2018
Link: https://doi.org/10.1038/..
 
?
12

Selective Optimization of Pranlukast to Farnesoid X Recepto..:

Schierle, Simone ; Schmidt, Jurema ; Kaiser, Astrid.
ChemMedChem.  13 (2018)  23 - p. 2530-2545 , 2018
Link: https://doi.org/10.1002/..
 
?
13

Structure-Based Approach toward Identification of Inhibitor..:

Heidenreich, David ; Moustakim, Moses ; Schmidt, Jurema...
Journal of Medicinal Chemistry.  61 (2018)  23 - p. 10929-10934 , 2018
Link: https://doi.org/10.1021/..
 
?
14

Boosting Anti-Inflammatory Potency of Zafirlukast by Design..:

Schierle, Simone ; Flauaus, Cathrin ; Heitel, Pascal...
Journal of Medicinal Chemistry.  61 (2018)  13 - p. 5758-5764 , 2018
Link: https://doi.org/10.1021/..
 
?
15

A Dual Modulator of Farnesoid X Receptor and Soluble Epoxid..:

Schmidt, Jurema ; Rotter, Marco ; Weiser, Tim...
Journal of Medicinal Chemistry.  60 (2017)  18 - p. 7703-7724 , 2017
Link: https://doi.org/10.1021/..
 
1-15